Microfluidics-on-a-chip for designing celecoxib-based amorphous solid dispersions: when the process shapes the product
Drug Delivery and Translational Research · 2025-02 · 15 (2) · 732-752
DOI: 10.1007/s13346-024-01633-7 ↗Kurz gefasst
Fachartikel in der Zeitschrift Drug Delivery and Translational Research, online erschienen am 11.06.2024. Verfasst von Joana Figueiredo und 4 weiteren Autor:innen. Beteiligte Einrichtung: Faculty of Pharmacy, University of Coimbra, Pólo das Ciências da Saúde, Azinhaga de Santa Comba, 3000-548, Coimbra, Portugal. Hauptthemen laut MEDLINE: Celecoxib, Lab-On-A-Chip Devices, Solubility. Die Arbeit wurde bisher 7-mal zitiert (Crossref) und nennt 78 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Fundação para a Ciência e a Tecnologia, Universidade de Coimbra.
Abstract (Originalsprache)
The fundamental idea underlying the use of amorphous solid dispersions (ASDs) is to make the most of the solubility advantage of the amorphous form of a drug. However, the drug stability becomes compromised due to the higher free energy and disorder of molecular packing in the amorphous phase, leading to crystallization. Polymers are used as a matrix to form a stable homogeneous amorphous system to overcome the stability concern. The present work aims to design ASD-based formulations under the umbrella of quality by design principles for improving oral drug bioavailability, using celecoxib (CXB) as a model drug. ASDs were prepared from selected polymers and tested both individually and in combinations, using various manufacturing techniques: high-shear homogenization, high-pressure homogenization, microfluidics-on-a-chip, and spray drying. The resulting dispersions were further optimized, resorting to a 3 2 full-factorial design, considering the drug:polymers ratio and the total solid content as variables. The formulated products were evaluated regarding analytical centrifugation and the influence of the different polymers on the intrinsic dissolution rate of the CXB-ASDs. Microfluidics-on-a-chip led to the amorphous status of the formulation. The in vitro evaluation demonstrated a remarkable 26-fold enhancement in the intrinsic dissolution rate, and the translation of this formulation into tablets as the final dosage form is consistent with the observed performance enhancement. These findings are supported by ex vivo assays, which exhibited a two-fold increase in permeability compared to pure CXB. This study tackles the bioavailability hurdles encountered with diverse active compounds, offering insights into the development of more effective drug delivery platforms. Graphical Abstract
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Faculty of Pharmacy, University of Coimbra, Pólo das Ciências da Saúde, Azinhaga de Santa Comba, 3000-548, Coimbra, Portugal.
- Coimbra Chemistry Centre, Institute of Molecular Sciences - IMS, Department of Chemistry, University of Coimbra, 3004-535, Coimbra, Portugal.
- Faculty of Pharmacy, University of Coimbra, Pólo das Ciências da Saúde, Azinhaga de Santa Comba, 3000-548, Coimbra, Portugal. csvitorino@ff.uc.pt.
- Coimbra Chemistry Centre, Institute of Molecular Sciences - IMS, Department of Chemistry, University of Coimbra, 3004-535, Coimbra, Portugal. csvitorino@ff.uc.pt.
ORCID-Profile: Carla Vitorino
Förderung
- Fundação para a Ciência e a Tecnologia
- Universidade de Coimbra
Zitieren
APA
Figueiredo, J., Mendes, M., Pais, A., Sousa, J., & Vitorino, C. (2025). Microfluidics-on-a-chip for designing celecoxib-based amorphous solid dispersions: when the process shapes the product. Drug Delivery and Translational Research, 15(2), 732-752. https://doi.org/10.1007/s13346-024-01633-7
Vancouver
Figueiredo J, Mendes M, Pais A, Sousa J, Vitorino C. Microfluidics-on-a-chip for designing celecoxib-based amorphous solid dispersions: when the process shapes the product. Drug Delivery and Translational Research. 2025;15(2):732-752. doi:10.1007/s13346-024-01633-7
BibTeX
@article{Figueiredo2025,
author = {Figueiredo, Joana and Mendes, Maria and Pais, Alberto and Sousa, João and Vitorino, Carla},
title = {Microfluidics-on-a-chip for designing celecoxib-based amorphous solid dispersions: when the process shapes the product},
journal = {Drug Delivery and Translational Research},
year = {2025},
volume = {15},
number = {2},
pages = {732--752},
doi = {10.1007/s13346-024-01633-7}
}
EUVIMED